Riskpilot← Back to searchSign inGet full accessStockholm IVF AB
ABDissolvedOrg 5569579799Medical specialists activities · NACE 8622Est. 201416 employees
Revenue 2022
SEK 26,8M
-6% vs 2021
EBITDA margin
-10.0%
-3475% vs 2021
Equity ratio
47.0%
Financial strength
Net profit 2022
SEK 17K
-98% vs 2021
| Revenue | SEK 26,8M | -6% |
| EBITDA | SEK -2,7M | -3475% |
| Net profit | SEK 17K | -98% |
| Total assets | SEK 7,8M | -24% |
| Equity | SEK 3,7M | -21% |
| Employees | 16 | — |
Legal name
Stockholm IVF AB
Org number
5569579799
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 januari 2014
Share capital
SEK 50 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av externa firmatecknaren
Company purpose
Bolaget skall bedriva fertilitetssjukvård och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 22 527 | 30 849 | 27 591 | 28 623 | 26 807 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 023 | 5 896 | 625 | −75 | −2 681 |
| Depreciation & amort. | −1 177 | −1 453 | −1 624 | −1 829 | −1 798 |
| EBIT | 2 846 | 4 443 | −999 | −1 904 | −4 479 |
| Net financials | −73 | −6 | −11 | −16 | −4 |
| Profit before tax | 2 773 | 437 | −1 010 | 980 | 17 |
| Tax | −614 | −98 | −0 | −4 | −0 |
| Net profit | 2 159 | 339 | −1 010 | 976 | 17 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 10 793 | 12 429 | 8 779 | 10 326 | 7 844 |
| Equity | 7 861 | 4 700 | 3 690 | 4 666 | 3 683 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 932 | 7 729 | 5 088 | 5 660 | 4 161 |
| Total debt | 2 932 | 7 729 | 5 088 | 5 660 | 4 161 |
EBITDA margin
-10.0%
This company
15.8%
Market median
-163% vs market
20182022
Equity ratio
47.0%
This company
38.2%
Market median
+23% vs market
20182022
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
20182022
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20182022
Asset turnover
3.42×
This company
1.12×
Market median
+205% vs market
20182022
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LJ External Signatory | External Signatory | 2022 |
PJ Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
MG External Signatory | External Signatory | 2020 – 2021 |
MB External Signatory | External Signatory | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2020 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LUARMIA S.L.
Stockholm IVF AB Board members of Stockholm IVF AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Jörgen Malmenskog | External Signatory | 0 companies |
| Mattias Gustaf Erik Olofson | External Signatory | 0 companies |
| Mats Börje Brännström | External Signatory | 0 companies |
| Per Johan Engstam | Chief Auditor | 0 companies |
| Klas Gustaf Brännström | Board of Directors | 0 companies |
| Eduardo Gonzalez Martinez | Chairman | 0 companies |
| Sven Nielsen | Board of Directors | 0 companies |
| Pia Maria Sofie Saldeen | Board of Directors | 0 companies |
| Esther Jimenez Gamero | Board of Directors | 0 companies |
| Aranda Amelia Rodriquez | Board of Directors | 0 companies |